MoneyWorks4Me

Piramal Pharma - Quaterly Results

03 Aug 2023 Evaluate
The June 2023 quarter revenue stood at Rs. 8464.30 millions, up 13.39% as compared to Rs. 7464.70 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2023 is Rs. -333.60 millions as compared to Net Loss of Rs. -171.20 millions of corresponding quarter ended June 2022Operating profit surged to 432.70 millions from the corresponding previous quarter of 404.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 8464.30 7464.70 13.39 8464.30 7464.70 13.39 34432.20 33404.20 3.08
Other Income 266.80 1066.10 -74.97 266.80 1066.10 -74.97 3410.70 2247.90 51.73
PBIDT 432.70 404.90 6.87 432.70 404.90 6.87 4386.00 7000.70 -37.35
Interest 338.00 203.10 66.42 338.00 203.10 66.42 1158.70 572.90 102.25
PBDT 94.70 201.80 -53.07 94.70 201.80 -53.07 3157.70 6277.00 -49.69
Depreciation 503.70 447.80 12.48 503.70 447.80 12.48 1920.80 1653.70 16.15
PBT -409.00 -246.00 66.26 -409.00 -246.00 66.26 1236.90 4623.30 -73.25
TAX -75.40 -74.80 0.80 -75.40 -74.80 0.80 541.90 947.90 -42.83
Deferred Tax -75.40 -74.80 0.80 -75.40 -74.80 0.80 154.20 -160.30 -196.19
PAT -333.60 -171.20 94.86 -333.60 -171.20 94.86 695.00 3675.40 -81.09
Equity 11933.20 11859.10 0.62 11933.20 11859.10 0.62 11933.20 11859.10 0.62
PBIDTM(%) 5.11 5.42 -5.75 5.11 5.42 -5.75 12.74 20.96 -39.22
Peers
Company Name CMP
Sun Pharma. Inds. 1846.30
Dr. Reddys Labs. 1221.50
Cipla 1392.30
Lupin 2071.65
Zydus Lifesciences 1213.10
View more..